Literature DB >> 4733238

Multiple forms of acetylcholinesterase from human erythrocytes.

D L Wright, D T Plummer.   

Abstract

1. Acetylcholinesterase from human erythrocytes was solubilized with Triton X-100 in strong salt solution and partially purified by (NH(4))(2)SO(4) fractionation. This preparation showed three main bands of enzyme activity after electrophoresis on polyacrylamide gel and incubation with either alpha-naphthyl acetate or acetylthiocholine as enzyme substrate. Two of the multiple forms were completely inhibited by 10mum-eserine and one only partially. Treatment with neuraminidase had no effect on the electrophoretic pattern; therefore sialic acid does not appear to determine or affect the ratios of the acetylcholinesterase multiple forms, unlike those of the serum cholinesterase. 2. Chromatography of the preparation on Sephadex G-200 revealed one major peak of enzyme activity and a suggestion of two minor zones of mol.wt. 546000, 184000 and 93000 (i.e. in the proportion 6:2:1). The main peak was almost completely separated from the Triton X-100 and the overall purification was about 600-fold. Further attempts to purify the enzyme by absorption on calcium phosphate gels were unsuccessful. 3. Electrophoresis of the enzyme preparation on a polyacrylamide gradient for 24h revealed three main bands that corresponded to the three values for molecular weights obtained by column chromatography. After 70h of electrophoresis a further three zones of activity developed making six molecular entities, the molecular weights of which were simple multiples of a monomer, thus resembling the cholinesterase found in serum.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4733238      PMCID: PMC1177730          DOI: 10.1042/bj1330521

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  19 in total

1.  The subunit molecular weight of acetylcholinesterase.

Authors:  David B. Millar; Melba A. Grafius
Journal:  FEBS Lett       Date:  1970-12-23       Impact factor: 4.124

2.  Multiple nature of acetylcholinesterase in nerve tissue.

Authors:  J BERNSOHN; K D BARRON; A R HESS
Journal:  Nature       Date:  1962-07-21       Impact factor: 49.962

3.  Tissue-specific and species-specific esterases.

Authors:  J PAUL; P FOTTRELL
Journal:  Biochem J       Date:  1961-02       Impact factor: 3.857

4.  The pH-stat and its use in biochemistry.

Authors:  C F JACOBSEN; J LEONIS; K LINDERSTROM-LANG; M OTTESEN
Journal:  Methods Biochem Anal       Date:  1957

5.  Human plasma cholinesterase isoenzymes.

Authors:  P Juul
Journal:  Clin Chim Acta       Date:  1968-02       Impact factor: 3.786

6.  Molecular properties of acetylcholinesterase.

Authors:  W Leuzinger; M Goldberg; E Cauvin
Journal:  J Mol Biol       Date:  1969-03-14       Impact factor: 5.469

7.  Human serum cholinesterase. I. Partial purification andnature of the heterogeneity of this system.

Authors:  P J Gaffney
Journal:  Biochim Biophys Acta       Date:  1970-06-23

8.  On the subunit structure of acetylcholinesterase.

Authors:  H C Froede; I B Wilson
Journal:  Isr J Med Sci       Date:  1970 Mar-Apr

9.  The gel-filtration behaviour of proteins related to their molecular weights over a wide range.

Authors:  P Andrews
Journal:  Biochem J       Date:  1965-09       Impact factor: 3.857

10.  The distribution of cholinesterase in cholinergic neurons demonstrated with the electron microscope.

Authors:  P R Lewis; C C Shute
Journal:  J Cell Sci       Date:  1966-09       Impact factor: 5.285

View more
  10 in total

Review 1.  Nonneuronal cholinergic system in human erythrocytes: biological role and clinical relevance.

Authors:  J P Lopes de Almeida; C Saldanha
Journal:  J Membr Biol       Date:  2010-03-30       Impact factor: 1.843

2.  Solubilization of human erythrocyte membrane glycoproteins by triton X-100.

Authors:  R S Pratt; G M Cook
Journal:  Biochem J       Date:  1979-05-01       Impact factor: 3.857

Review 3.  Neuromuscular transmission and its pharmacological blockade. Part 1: Neuromuscular transmission and general aspects of its blockade.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

4.  Acetylcholinesterase conformational states influence nitric oxide mobilization in the erythrocyte.

Authors:  Pedro Teixeira; Nuno Duro; Patrícia Napoleão; Carlota Saldanha
Journal:  J Membr Biol       Date:  2015-02-05       Impact factor: 1.843

5.  Modulation of erythrocyte acetylcholinesterase activity and its association with G protein-band 3 interactions.

Authors:  F A Carvalho; J P Lopes de Almeida; T Freitas-Santos; C Saldanha
Journal:  J Membr Biol       Date:  2009-03-18       Impact factor: 1.843

6.  Human syncytiotrophoblast membrane proteins defined using a heterologous antiserum.

Authors:  A Whyte; N Ragge; Y W Loke; L Thiry
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

7.  Regulatory effects of polyamines on membrane-bound acetylcholinesterase.

Authors:  A Kossorotow; H U Wolf; N Seiler
Journal:  Biochem J       Date:  1974-10       Impact factor: 3.857

8.  Characterization of lipid-protein interactions in acetylcholinesterase lipoprotein extracted from bovine erythrocytes.

Authors:  G Beauregard; B D Roufogalis
Journal:  Biochem J       Date:  1979-04-01       Impact factor: 3.857

9.  Solubilization and some properties of a semicarbazide-sensitive amine oxidase in brown adipose tissue of the rat.

Authors:  M A Barrand; B A Callingham
Journal:  Biochem J       Date:  1984-09-01       Impact factor: 3.857

10.  Evaluation of acetylcholinesterase and adenosine deaminase activities in brain and erythrocytes and proinflammatory cytokine levels in rats submitted to neonatal hypoxia-ischemia model.

Authors:  Victor Camera Pimentel; Jéssica Lopes Gomes; Daniela Zanini; Fátima Husein Abdalla; Pauline da Costa; Jamile Fabbrin Gonçalves; Marta Maria Medeiros Frescura Duarte; Maria Beatriz Moretto; Vera Maria Morsch; Maria Rosa Chitolina Schetinger
Journal:  Mol Cell Biochem       Date:  2013-03-21       Impact factor: 3.396

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.